SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001096906-21-001061
Filing Date
2021-05-07
Accepted
2021-05-07 17:25:36
Documents
47
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING sgbi-20210331.htm   iXBRL 10-Q/A 687036
2 CERTIFICATION sgbi_ex31z1.htm EX-31.1 7180
3 CERTIFICATION sgbi_ex31z2.htm EX-31.2 7757
4 CERTIFICATION sgbi_ex32z1.htm EX-32.1 4324
  Complete submission text file 0001096906-21-001061.txt   2622451

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgbi-20210331_cal.xml EX-101.CAL 26987
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgbi-20210331_def.xml EX-101.DEF 50793
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgbi-20210331_lab.xml EX-101.LAB 139151
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgbi-20210331_pre.xml EX-101.PRE 122820
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgbi-20210331.xsd EX-101.SCH 51990
10 EXTRACTED XBRL INSTANCE DOCUMENT sgbi-20210331_htm.xml XML 365372
Mailing Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025
Business Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025 011 49 (40) 6093120
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 000-29233 | Film No.: 21904109
SIC: 2834 Pharmaceutical Preparations